Publicacións nas que colabora con Ana Isabel Rodríguez Pérez (13)
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
The role of the brain renin-angiotensin system in Parkinson´s disease
Translational Neurodegeneration, Vol. 13, Núm. 1
2023
-
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Brain, Behavior, and Immunity, Vol. 108, pp. 255-268
-
Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
Antioxidants, Vol. 12, Núm. 12
2022
-
Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity
Frontiers in Medicine, Vol. 9
-
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
npj Parkinson's Disease, Vol. 8, Núm. 1
-
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
Biomedicines, Vol. 10, Núm. 2
-
Parkinson's disease and diabetes mellitus: Common mechanisms and treatment repurposing
Neural Regeneration Research, Vol. 17, Núm. 8, pp. 1652-1658
2021
-
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19
Journal of Autoimmunity, Vol. 122
-
Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists
Frontiers in Neuroendocrinology, Vol. 62
-
Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19
Clinical Science, Vol. 135, Núm. 3, pp. 465-481
2020
-
Interaction between brain angiotensin and dopaminergic systems and Parkinson’s disease
Genetics, Neurology, Behavior, and Diet in Parkinson’s Disease: The Neuroscience of Parkinson’s Disease, Volume 2 (Elsevier), pp. 463-477
2018
-
Anatomía general y anatomía del aparato locomotor
Círculo Rojo